S&P 500 Futures
(0.16%) 5 336.00 points
Dow Jones Futures
(0.06%) 40 161 points
Nasdaq Futures
(0.25%) 18 682 points
Oil
(-0.54%) $79.63
Gas
(1.94%) $2.68
Gold
(0.40%) $2 427.00
Silver
(0.69%) $31.48
Platinum
(-1.55%) $1 073.10
USD/EUR
(0.10%) $0.921
USD/NOK
(0.16%) $10.69
USD/GBP
(0.06%) $0.788
USD/RUB
(-0.35%) $90.65

Realtime updates for Trevi Therapeutics Inc [TRVI]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated17 May 2024 @ 16:00

-2.46% $ 2.77

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):
Profile picture for Trevi Therapeutics Inc

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions...

Stats
Today's Volume 66 965.00
Average Volume 246 185
Market Cap 195.11M
EPS $0 ( 2024-05-09 )
Next earnings date ( $-0.110 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -8.15
ATR14 $0.0120 (0.43%)
Insider Trading
Date Person Action Amount type
2024-05-10 Good Jennifer L Buy 4 578 Common Stock
2024-05-10 Good Jennifer L Sell 4 578 Common Stock
2024-05-10 Good Jennifer L Sell 4 578 Stock Option (right to buy)
2024-02-15 Galletta Christopher Buy 28 500 Stock Option (right to buy)
2024-02-15 Simon Farrell Buy 175 000 Stock Option (right to buy)
INSIDER POWER
79.78
Last 98 transactions
Buy: 24 441 332 | Sell: 1 388 191

Volume Correlation

Long: 0.13 (neutral)
Short: -0.54 (weak negative)
Signal:(42.223) Neutral

Trevi Therapeutics Inc Correlation

10 Most Positive Correlations
ADSE0.94
MEDP0.937
AIHS0.934
MOR0.934
SPBC0.933
SMCI0.933
RTH0.932
PDP0.926
NVDA0.925
CLBT0.925
10 Most Negative Correlations
CYAN-0.95
WTER-0.943
SSRM-0.942
BIOL-0.94
WISA-0.938
SABR-0.928
FINW-0.927
ALNY-0.926
UTMD-0.923
LTRX-0.916

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Trevi Therapeutics Inc Correlation - Currency/Commodity

The country flag 0.42
( neutral )
The country flag 0.54
( weak )
The country flag 0.00
( neutral )
The country flag 0.68
( moderate )
The country flag -0.20
( neutral )
The country flag -0.31
( neutral )

Trevi Therapeutics Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-123 000 (0.00 %)
EPS: $-0.290
FY 2023
Revenue: $0
Gross Profit: $-123 000 (0.00 %)
EPS: $-0.290
FY 2022
Revenue: $0
Gross Profit: $-43 000.00 (0.00 %)
EPS: $-0.450
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.830

Financial Reports:

No articles found.

Trevi Therapeutics Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Trevi Therapeutics Inc

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo Pharmaceuticals Inc. to develop and commercialize products incorporating nalbuphine hydrochloride in any formulation. The company was incorporated in 2011 and is headquartered in New Haven, Connecticut.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators